Identification of a vaccine against schistosomiasis using bioinformatics and molecular modeling tools

Infection, Genetics and Evolution

Volumn 20, Issue , 2013, Pages 83-95

  de Oliveira Lopes, Débora ^a   de Oliveira, Flávio Martins ^a   do Vale Coelho, Ivan Evangelista ^a   de Oliveira Santana, Karina Talita ^a   Mendonça, Flávia Costa ^a   Taranto, Alex Gutterres ^a   dos Santos, Luciana Lara ^a   Miyoshi, Anderson ^b   de Carvalho Azevedo, Vasco Ariston ^b   Comar, Moacyr ^a  

^a FEDERAL UNIVERSITY OF SÃO JOÃO DEL REI   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bioinformatics; Molecular modeling; Schistosoma mansoni; Vaccine

Indexed keywords

EPITOPE; GLYCOPEPTIDE; VACCINE;

ANTIGEN STRUCTURE; ARTICLE; BIOINFORMATICS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA SEQUENCE; GENETIC DATABASE; IMMUNE RESPONSE; INFECTION PREVENTION; MOLECULAR DYNAMICS; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; PROMOTER REGION; PROTEIN DATABASE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; THERMODYNAMICS; VACCINE PRODUCTION;

SCHISTOSOMA MANSONI;

ALIGNMENT SEARCH TOOL; BIOINFORMATICS; BLAST; KNOWN PROTEINS; KP; MD; MOLECULAR DYNAMICS; MOLECULAR MODELING; PDB; PROTEIN DATA BANK; RMSD; ROOT MEAN SQUARE DEVIATION; SCHISTOSOMA MANSONI; UNKNOWN PROTEINS; UP; VACCINE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; DATABASES, PROTEIN; EPITOPES; HELMINTH PROTEINS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTOZOAN VACCINES; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SIGNAL TRANSDUCTION;

EID: 84883652523     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.08.007     Document Type: Article

References (70)

1. Abbas A.K., Lichtman A.H., Pillai S. Imunologia Celular e Molecular [Cellular and Molecular Immunology] 2008, Elsevier, Riode Janeiro, 101-129. 6nd ed.
2. Agiro L., Henri S., Dessein H., Kouriba B., Dessein A.J., Bourgois A. Induction of protection against S.mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorbtion with GM-CSFonalum. Vaccine 2000, 18:2033-2038.
3. Agudelo W.A., Patarroyo M.E. Quantum chemical analysis of MHC-peptide interactions for vaccine design. Mini Rev. Med. Chem. 2010, 10:746-758.
4. Ahmed H.M., Romeih M.H., Sheriff S.A., Fathom F.A., Saber M.A. Protection against Schistosoma mansoni infection with recombinant schistosomula 21.7kDa protein. Arab. J. Biotech. 2001, 24:229-249.
5. Andrade Z.A. Schistosomiasis in Brazil after nearly a century of research. Rev. Soc. Brazil Med. 2002, 35:509-513.
6. Andrade B.S., Taranto A.G., Góes-neto A., Duarte A.A. Comparative modeling of DNA and RNA polymerases from Moniliophthora Perniciosa mitochondrial plasmid. Theor. Biol. Med. Model. 2009, 6:1-2.
7. Bergquist N.R. Schistosomiasis vaccine development: approaches and prospects. Mem. Inst. Oswaldo Cruz. 1995, 90:221-227.
8. BLAST-Basic Local Alignment Search Tool []. http://blast.ncbi.nlm.nih.gov/Blast.cgi.
9. Bordoli L., Kiefer F., Arnold K., Benkert P., Battey J., Schwede T. Protein structure homology modeling using SWISS-MODEL workspace. Nat. Protoc. 2009, 4:1-13.
10. Cardoso F.C., Pacífico R.N.A., Mortara R.A., Oliveira S.C. Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies. Clin. Exp. Immunol. 2006, 144:382-391.
11. Case D.A., Darden T.A., Cheatham T.E., Simmerling C.L., Wang J., Duke R.E., Luo R., Merz K.M., Wang B., Pearlman D.A., Crowley M., Brozell S., Tsui V., Gohlke H., Mongan J., Hornak V., Cui G., Beroza P., Schafmeister C., Caldwell J.W., Ross W.S., Kollman P.A. AMBER 11: User Manual 2011, University of California, San Francisco, p. 320.
12. Castro-Borges W., Dowle A., Curwen R.S., Thomas-Oates J., Wilson R.A. Enzymatic shaving of the tegument surface of live schistosomes for proteomic analysis: arational approach to select vaccine candidates. PLoS Negl. Trop. Dis. 2011, 5(3):993.
13. Chandra S., Singh T.R. Linear B cell epitope prediction for epitope vaccine design against meningococcal disease and their computational validations through physicochemical properties. Netw. Model Anal. Health Inform. Bioinform. 2012, 1:153-159.
14. Chandra S., Singh D., Singh T.R. Prediction and characterization of T-cell epitopes for epitope vaccine design from outer membrane protein of Neisseria meningitidis serogroup B. Bioinformation 2010, 5(4):155-161.
15. Da'Dara A.A., Skelly P.J., Walker C.M., Harn D.A. ADNA - prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection. Parasite Immunol. 2003, 25(8-9):429-437.
16. Dalton J.A.R., Jackson R.M.J. Homology - modelling protein - ligand interactions: Allowing for ligand-induced conformational change. J. Mol. Biol. 2010, 399:645-661.
17. de Andrade D.V.G., Góes-Neto A., Comar Junior M., Taranto A.G. Comparative modeling and QM/MM studies of cysteine protease mutant of Theobroma cacao. Int. J. Quantum Chem. 2012, 112:3164-3168.
18. dos Santos J.R., Taranto, A.G., Assis, S.A., Góes-neto, A.M.C. Homology modeling of pyrophosphorylase, enzyme involved in Chitin pathway of Moniliophthora Perniciosa. Int. J. Bioinform. Res. Appl. (IJBRA) 2009, 5:133-153.
19. Duan Y., Wu C., Chowdhury S., Lee M.C., Xiong G., Zhang W., Yang R., Cieplak P., Luo R., Lee T. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculation. J. Comput. Chem. 2003, 24:1999-2012.
20. Fonseca C.T., Neto E.C., Kalil J., Jesus A.R., Oliveira R.C., Carvalho E.M., Oliveira S.C. Identification of immuno dominant epitopes of Schistosoma mansoni vaccine candidate antigens using Human T cells. Mem. Inst. Oswaldo Cruz. 2004, 99:63-66.
21. Gauss View, Version 5, Dennington, R., Keith, T., Millam, J. Semichem Inc. Shawnee Mission, KS, 2009.
22. Gaussian 09, Revision A.1, Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Mennucci, B., Petersson, G.A., Nakatsuji, H., Caricato, M., Li, X., Hratchian, H.P., Izmaylov, A.F., Bloino, J., Zheng, G., Sonnenberg, J.L., Hada, M., Ehara, M., Toyota, K., Fukuda, R., Hasegawa, J., Ishida, M., Nakajima, T., Honda, Y., Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, Jr., J. A.; Peralta, J.E.; Ogliaro, F.; Bearpark, M.; Heyd, J.J., Brothers, E., Kudin, K.N., Staroverov, V.N., Kobayashi, R., Normand, J., Raghavachari, K., Rendell, A., Burant, J.C., Iyengar, S.S., Tomasi, J., Cossi, M., Rega, N., Millam, J.M., Klene, M., Knox, J.E., Cross, J.B., Bakken, V., Adamo, C., Jaramillo, J., Gomperts, R., Stratmann, R.E., Yazyev, O., Austin, A.J., Cammi, R., Pomelli, C., Ochterski, J.W., Martin, R.L., Morokuma, K., Zakrzewski, V.G., Voth, G.A., Salvador, P., Dannenberg, J.J., Dapprich, S., Daniels, A.D., Farkas, Ö., Foresman, J.B., Ortiz, J.V., Cioslowski, J., Fox, D.J. Gaussian, Inc., Wallingford CT, 2009.
23. Gene DB [http://www.genedb.org/Homepage].
24. Hawkins, G.D., Cramer, C.J., Truhlar, D.G. 1995.PairwiseSoluteDescreeningofSoluteChargesfromaDielectricMedium.ChemPhysLett.246,122-129.
25. Hawkins G.D., Cramer C.J., Truhlar D.G. Parametrized models of aqueous free energies of solvation based on pairwise descreening of solute atomic charges from a dielectric medium. J. Phys. Chem. 1996, 100:19824-19839.
26. Hinrichsen S.L. Dip-Doenças Infeccios as e Parasitarias [IPD-Infectious and Parasitic Diseases] 2005, Guanabara Koogan, Riode Janeiro, 323.
27. Holtje, H.D., Sippl, W., Rognan, D., Folkers, G., 2003. In: Molecular Modeling-Basic Principles and Applications. Edited by WILEY-VCH. Darmstadt: WILEY-VCH Verlag Gmbh & Co. KGaA.181.
28. Hotez P.J., Bethony J.M., Diemert D.J., Pearson M., Loukas A. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat. Rev. Microbiol. 2010, 8:814-826.
29. Hsu S.C., Tsai T.H., Kawasaki H., Chen C.H., Plunkett B., Lee R.T., Lee Y.C., Huang S.K. Antigen coupled with Lewis-x trisaccharides elicits potent immune responses in mice. J. Allergy Clin. Immunol. 2007, 119:1522-1528.
30. Ivanoff N., Phillips N., Schacht A.M., Heydari C., Capron A., Riveau G. Mucosal vaccination against schistosomiasis using liposome-associated Sm 28kD aglutathione S-transferase. Vaccine 1996, 14:1123-1131.
31. Laskowski R.A., Macarthur M.W., Moss D.S., Thornton J.M.J. PROCHECK: a program to check the stereochemical quality of protein structure. J. Appl. Crystallog. 1993, 26:283-291.
32. Lee M.C., Duan Y. Distinguish protein decoys by using as coring function based a new Amber force field short molecular dynamics simulations, and the generalized Born solvent model. Proteins 2004, 55:620-634.
33. Lopes D.O., Paiva L.F., Martins M.A., Cardoso F.C., Rajão M.A., Pinho J.M., Caliari M.V., Oliveira R.C., Mello S.M., Leite L.C.C., Oliveira S.C. Sm21.6: a novel EF-hand family protein member located on the surface of Schistosoma mansoni adult worm that failed to induce protection against challenge infection but reduced liver pathology. Vaccine 2009, 27:4127-4135.
34. McManus D.P., Loukas A. Current Status of Vaccines for Schistosomiasis. Clin. Microbiol. Rev. 2008, 21:225-242.
35. Mendes R.G.P.R., Gusmão M.A.N., Maia A.C.R.G., Detoni M.L., Porcino G.N., Soares T.V., Juliano M.A., Juliano L., Coelho P.M.Z., Lenzi H.L., Pinto P.F., Vasconcelos E.G. Immuno stimulatory property of a synthetic peptide belonging to the soluble ATP diphosphohydro-lase isoform (SmATPDase2) and immunolocalisation of this protein in the Schistosoma mansoni egg. Mem. Inst. Oswaldo Cruz. 2011, 106:808-813.
36. Milicic A., Kaur R., Reyes-Sandoval A., Tang C.K., Honeycutt J., Perrie Y., Hill A.V. Small cationic DDA TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses. PLoS One 2012, 7(3):e34255.
37. MutAlin4.1-Multiple sequence alignment http://multalin.toulouse.inra.fr/multalin/multalin.html.
38. National Center for Biotechnology Information-NCBI []. http://www.ncbi.nlm.nih.gov.
39. NetMHC3.2 Server []. http://www.cbs.dtu.dk/services/NetMHC/.
40. Oliveira S.C., Fonseca C.T., Cardoso F.C., Farias L.P., Leite L.C. Recent advances in vaccine research against schistosomiasis in Brazil. Acta Trop. 2008, 108(2-3):256-262.
41. Pantarotto D., Partidos C.D., Hoebeke J., Brown F., Kramer E., Briand J.P., Muller S., Prato M., Bianco A. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem. Biol. 2003, 10(10):961-966.
42. Pinheiro C.S., Martins V.P., Assis N.R.G., Figueiredo B.C.P., Morais S.B., Azevedo V., Oliveira S.C. Computational vaccinology: an important strategy to discover new potential S. mansoni vaccine candidates. J. Biomed. Biotechnol. 2011.
43. Pinheiro A.A.F., Taranto A.G., Duarte A.A., Góes-Neto A., da Hora Júnior B.T., Pereira G.A.G., dos Santos Júnior M.C., de Assis A.S. Homology modeling studies of beta(1,3)-d-glucan synthase of Moniliophthora perniciosa. Int. J. Quantum Chem. 2012, 112:3356-3363.
44. Ramachandran G.N., Ramakrishnan C., Sasisekharan V. Stereochemistry of polypeptide chain configurations. J. Mol. Biol. 1963, 7:95-99.
45. Rankpep-Prediction of binding peptides to Class I and Class II MHC molecules []. http://imed.med.ucm.es/Tools/rankpep.html.
46. Richter D., Incani R.N., Harn D.A. Lacto-N-FucopentaoseIII (Lewisx) a target of the antibody response in mice vaccinated with irradiated cercariae of Schistosoma mansoni. Infect. Immun. 1996, 64:1826-1831.
47. Rollinson D., Southgate V.R. The Biology of Schistosomes from Genes Tolatrines 1987, D. Rollinson & AJG. Simpson, London, 1-49.
48. Santos Junior M.C., Gonçalves P.A., Taranto A.G., Koblitz M.G.B., Góes-Neto A., Pirovani C.P., Cascardo J.C.M., Cruz S.H., Zingali R.B., Pereira G.A.G., Dias C.V., Assis A.S. Purification, characterization and structural determination of UDP-N-Acetylglucosamine pyrophosphorylase produced by Moniliophthora perniciosa. J. Braz. Chem. Soc. 2011, 22:1015-1023.
49. Sepulveda J., Tremblay J.M., DeGnore J.P., Skelly P.J., Shoemaker C.B. Schistosoma mansoni host-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis-resistantrats. Int. J. Parasitol. 2010, 40:1407-1417.
50. Shahlaei M., Sobhani A.M., Mahnam K., Fassihi A., Saghaie L., Mansourian M. Homology modeling of human CCR5 and analysis of its binding properties through molecular docking and molecular dynamics simulation. Biochim. Biophys. Acta. 1808, 2011:802-817.
51. Signal PServer3.0 []. http://www.cbs.dtu.dk/services/SignalP.
52. Silva Júnior J.J., Comar M., Ferreira B.A., Taranto A.G. Construção do Receptor CYSLTR1 por Modelagem Comparativa. Rev. Ciênc. Farm. Básica e Apl. 2012, 33:591-596.
53. SOSUI1.11-Classification and Secondary Structure Prediction of Membrane Proteins []. http://bp.nuap.nagoya-u.ac.jp/sosui/sosui_submit.html.
54. Souza C.P., Araújo N., Jannotti L.K., Gazzinelli G. Fatores que podem afetar a criação e manutenção de caramujos infectados e a produção de cercárias de Schistosoma mansoni [Factors that might affect the creation and maintenance of infected snails and the production of Schistosoma mansoni cercariae]. Mem. Inst. Oswaldo Cruz. 1987, 82:73-79.
55. Stewart J.J.P. Optimization of parameters for semi empirical methods V: Modification of NDDO approximations and application to 70 elements. J. Mol. Model. 2007, 13:1173.
56. Still W.C., Tempczyk A., Hawley R.C., Hendrickson T. Semianalytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 1990, 112:6127-6129.
57. SYFPEITHI-Epitope Prediction []. http://www.SYFPEITHI.de/Scripts/MHCServer.dll/EpitopePrediction.htm.
58. Szabadka Z., Grolmusz V. High throughput processing of the structural information in the protein data bank. J. Mol. Graph Model. 2007, 25:831-836.
59. Tendler M., Simpson A.J. The biotechnology-value chain: development of Sm 14 as a schistosomiasis vaccine. Acta Trop. 2008, 108:263-266.
60. Tendler M., Brito C.A., Vilar M.M., Freire N.S., Diogo C.M., Almeida M.S., Delbem A.C., DaSilva J.F., Savino W., Garratt R.C., Katz N., Simpson A.S. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc. Natl. Acad. Sci. USA 1996, 93:269-273.
61. TMHMM Server v.2.0-Prediction of Transmembrane hélices in proteins []. http://www.cbs.dtu.dk/services/TMHMM-2.0.
62. TMpred-Predicition of transmembrane regions and orientation []. http://www.ch.embnet.org/software/TMPRED_form.html.
63. Tran M.H., Pearson M.S., Bethony J.M., Smyth D.J., Jones M.K., Duke M., Don T.A., McManus D.P., Correa-Oliveira R., Loukas A. Tetraspanins on the surface of Schistosoma mansonia reprotective antigens against schistosomiasis. Nat. Med. 2006, 12(7):835-840.
64. Van Roon A.M.M., Vande Vijver K.K., Jacobs W., Van Marck E.A., Van Dam G.J., Hokke C.K., Deelder A.M. Discrimination between the anti-monomeric and the anti-multimeric Lewis X response inmurine schistosomiasis. Microb. Infect. 2004, 6:1125-1132.
65. Wang J., Wolf R.M., Caldwell J.W., Kollamn P.A., Case D.A. Development and testing of a general amber force field. J. Comput. Chem. 2004, 25:1157-1174.
66. Wu W., Cai P., Chen Q., Wang H. Identification of novel antigens within the Schistosoma japonicum tetraspanin family based on molecular characterization. Acta Trop. 2011, 117:216-224.
67. Yandar N., Pastorin G., Prato M., Bianco A., Patarroyo M.E., Lozanoa J.M. Immunological profile of a Plasmodium vivax AMA-1N-terminuspeptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model. Vaccine 2008, 26:5864-5873.
68. Yoshino T.P., Boyle J.P., Humphries J.E. Receptor-ligand interactions and cellular signalling at the host-parasite interface. Parasitology 2011, 123:143-157.
69. Zhang L., Yang Y., Yang X., Zhao J., Yang J., Liu F., Zhang Z., Wu G., Su C. T cell epitope-based peptide- DNA dual vaccine induces protective immunity against Schistosoma japonicum infection in C57BL/6J mice. Microbes Infect. 2008, 10(3):251-259.
70. Zhaoa B.P., Chena L., Zhanga Y.L., Yanga J.M., Jiaa K., Suia C.Y., Yuana C.X., Lina J.J., Fenga X.G. In silico prediction of binding of promiscuous peptides to multiple MHC class-II molecules identifies the Th1 cell epitopes from secreted and transmembrane proteins of Schistosoma japonicumin BALB/cmice. Microb. Infect. 2011, 13:709-719.